BrightSpring Health Services’ Specialty Pharmacy Onco360® Celebrates Excellent Patient Care and Preferred Pharmacy Status
BrightSpring Health Services, Inc. (BTSG)
Company Research
Source: GlobeNewswire
LOUISVILLE, Ky., March 14, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) announced today that its company, Onco360®, one of the nation’s largest independent oncology pharmacies, is now the national specialty pharmacy network partner for a first-in-class, XPO-1 inhibitor, XPOVIO® (selinexor) to treat patients with multiple myeloma. Onco360® currently has 116 limited distribution drugs in its portfolio, in partnership with pharmaceutical and biotech companies. While multiple myeloma is an incurable disease involving plasma cells, this innovative drug has been approved to treat patients with multiple myeloma by diffusing large B-cell lymphoma (DLBCL) and help to extend patients’ lives. “At BrightSpring Health Services, we are proud of our leading service lines like Onco360® as we continue to innovate in the health care industry and provide patients with life-improving and life-sustaining treatments,” said Brigh
Show less
Read more
Impact Snapshot
Event Time:
BTSG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BTSG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BTSG alerts
High impacting BrightSpring Health Services, Inc. news events
Weekly update
A roundup of the hottest topics
BTSG
News
- BrightSpring Health Services, Inc. (NASDAQ: BTSG) had its price target raised by analysts at Wells Fargo & Company from $15.00 to $16.00. They now have an "overweight" rating on the stock.MarketBeat
- BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 GuidanceGlobeNewswire
- BrightSpring Health Services, Inc. Welcomes Timothy A. Wicks to Board of DirectorsGlobeNewswire
- BrightSpring Health Services Specialty Pharmacy Onco360® Selected as National Pharmacy Partner for Voydeya®GlobeNewswire
- BrightSpring Health Services, Inc. to Announce First Quarter 2024 Financial Results on May 2, 2024, and Participate in the Bank of America 2024 Healthcare ConferenceGlobeNewswire
BTSG
Earnings
- 5/2/24 - Miss
BTSG
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 4/26/24 - Form 8-K
- BTSG's page on the SEC website